Sergio A. Jiménez

Active 1971–2025

Also published as
Sergio A. Jimenez
115
Papers
23,151
Citations
90
h-index
114
i10-index

Citations

Citations per year for Sergio A. Jiménez1972: 15 citations1973: 23 citations1974: 21 citations1975: 12 citations1976: 16 citations1977: 10 citations1978: 3 citations1979: 15 citations1980: 7 citations1981: 10 citations1982: 17 citations1983: 15 citations1984: 11 citations1985: 18 citations1986: 18 citations1987: 32 citations1988: 38 citations1989: 47 citations1990: 85 citations1991: 51 citations1992: 68 citations1993: 62 citations1994: 63 citations1995: 58 citations1996: 82 citations1997: 55 citations1998: 62 citations1999: 80 citations2000: 70 citations2001: 95 citations2002: 85 citations2003: 102 citations2004: 124 citations2005: 102 citations2006: 125 citations2007: 129 citations2008: 132 citations2009: 135 citations2010: 141 citations2011: 141 citations2012: 122 citations2013: 125 citations2014: 125 citations2015: 186 citations2016: 195 citations2017: 193 citations2018: 160 citations2019: 635 citations2020: 628 citations2021: 592 citations2022: 459 citations2023: 328 citations2024: 518 citations2025: 249 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,286 citing papers, 25.6% of this breakdownChina: 1,099 citing papers, 12.3% of this breakdownUnited Kingdom: 622 citing papers, 7% of this breakdownItaly: 577 citing papers, 6.5% of this breakdownGermany: 453 citing papers, 5.1% of this breakdownJapan: 400 citing papers, 4.5% of this breakdownFrance: 356 citing papers, 4% of this breakdownCanada: 323 citing papers, 3.6% of this breakdownSwitzerland: 238 citing papers, 2.7% of this breakdownNetherlands: 223 citing papers, 2.5% of this breakdownAustralia: 190 citing papers, 2.1% of this breakdownSpain: 186 citing papers, 2.1% of this breakdown
0%25.6%Other 22%

Fields

  • Medicine69.6%
  • Biochemistry, Genetics and Molecular Biology21.3%
  • Materials Science2.6%
  • Immunology and Microbiology2.5%
  • Neuroscience1.1%
  • Engineering0.7%
  • Other2.2%

Topics

  • Systemic Sclerosis and Related Diseases8.8%
  • Osteoarthritis Treatment and Mechanisms6.9%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.7%
  • Inflammatory Myopathies and Dermatomyositis2.6%
  • Cell Adhesion Molecules Research1.9%
  • Dermatologic Treatments and Research1.8%
  • Other74.3%

Coauthors

All papers

Open in search
  1. Osteoarthritis cartilage histopathology: grading and staging

    Authors: , , , , , , , - Osteoarthritis and Cartilage 2005 cited by 2,367

  2. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 cited by 3,406

  3. Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases

    Authors: , - Physiological Reviews 2019 cited by 652

  4. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis

    Authors: , - Osteoarthritis and Cartilage 2006 cited by 682

  5. Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic Disorders

    Authors: , , - American Journal Of Pathology 2011 cited by 574

  6. Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases

    Authors: , , - Journal of Clinical Medicine 2016 cited by 274

  7. Human Fibrotic Diseases: Current Challenges in Fibrosis Research

    Authors: , , , - Methods in molecular biology 2017 cited by 159

  8. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH

    Authors: , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 96

  9. Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts

    Authors: , , - Biochemical Journal 1987 cited by 590

  10. Isolation, characterization, and localization of cardiac collagen type VI. Associations with other extracellular matrix components.

    Authors: , , - Circulation Research 1992 cited by 136

  11. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles J. Yeo, Masaya Jimbo, Joseph A. Cozzitorto, Jonathan R. Brody, Kathleen Delgrosso, John S. Mattick, Paolo Fortina, Isidore Rigoutsos - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 415

  12. Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1

    Authors: , , , - PLoS ONE 2016 cited by 116

  13. Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target

    Authors: , - Journal of Clinical Medicine 2021 cited by 54

  14. Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies

    Authors: , , - Annals of Internal Medicine 2010 cited by 228

  15. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis–Associated Interstitial Lung Disease

    Authors: , , , , - Arthritis & Rheumatology 2015 cited by 117

  16. A disease severity scale for systemic sclerosis: development and testing.

    Authors: , , , , , , , , , , , , , , , , - 1999 cited by 445

  17. Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

    Authors: , - Annals of Internal Medicine 2004 cited by 295

  18. Pulmonary and Activation-Regulated Chemokine Stimulates Collagen Production in Lung Fibroblasts

    Authors: , , , , , , , , - American Journal of Respiratory Cell and Molecular Biology 2003 cited by 157

  19. The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases

    Authors: , - Clinical and Translational Medicine 2015 cited by 140

  20. Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes

    Authors: , , , , - Osteoarthritis and Cartilage 2004 cited by 137

  21. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Lara D. Veeken 2019 cited by 72

  22. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

    Authors: , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2002 cited by 334

  23. Role of Endothelial to Mesenchymal Transition in the Pathogenesis of the Vascular Alterations in Systemic Sclerosis

    Authors: - ISRN Rheumatology 2013 cited by 127

  24. Caveolin-1−/− Null Mammary Stromal Fibroblasts Share Characteristics with Human Breast Cancer-Associated Fibroblasts

    Authors: , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2009 cited by 118